UNSPSC 51142528: Ifenprodil

This classification denotes a platelet aggregation inhibitor, antiparkinson agent, and anticonvulsant with the molecular formula 2C21H27NO2.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 89CTB4XUF7, chemically known as 4-benzyl-1-(beta,4-dihydroxy-alpha-methylphenethyl)piperidinium hydrogen tartrate but generally known as ifenprodil tartrate, which bears US NIH Compound Identifier 134832.

UNSPSC 51142528 Ifenprodil is a Commodity code that nominally identifies a single pharmaceutical ingredient, but recent state and local solicitations under this code show no activity aligned with ifenprodil procurement itself. Instead, the tagged opportunities involve broader pharmaceutical and health-supply sourcing: naloxone and drug-deactivation systems for community health support, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing. The code's nominal scope does not align with the work actually being solicited. State and local issuing bodies using this code include county health departments, state health and human services agencies, and cooperative purchasing alliances serving multiple jurisdictions across state and local government entities.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug-deactivation systems annually through quarterly deliveries, with a fixed-fee contract structure and two-year initial term plus one-year renewal option. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, soliciting vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program to establish direct contracting between the state's pharmacy benefit program and manufacturers outside traditional pharmacy benefit manager and group purchasing organization arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, released RFP S1070000015802 on January 20, 2026, with a response deadline of March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon, requiring vendor pricing submission through authorized wholesalers and cGMP and DSCSA compliance. The code shows limited relevance to ifenprodil itself and does not support focused pursuit under its nominal scope.